Total
0
Shares
BOD Australia (ASX:BOD) - CEO, Jo Patterson - The Market Herald
CEO, Jo Patterson
Sourced: Jo Patterson
  • Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness
  • More than 2000 leading retailers such as Coles, Priceline and Chemist Warehouse will receive these products
  • This launch marks the first hemp-based range for Swisse in Australia
  • The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched
  • Bod's share price is up a steady 21.4 per cent and shares are trading for 17 cents each

Medicinal cannabis company Bod Australia (BDA) has launched nine hemp-based products in collaboration with Swisse Wellness.

More than 2000 stores will receive these products and they will initially be available in leading retailers such as Coles, Priceline, and Chemist Warehouse.

"Launching nine products with such as recognised and trusted brand in Swisse is game-changing for Bod," CEO Jo Patterson said.

"We anticipate considerable consumer uptake once stock is available for purchase. We look forward to providing regular updates to shareholders as sales build," she added.

Following a partnership that Bod secured with Swisse's parent company, Health and Happiness Group, in 2019, this launch marks the first of the Swisse hemp-based range in Australia.

The range is primarily made-up of skincare products, but soft gel caps containing hemp seed oil will also be launched.

Initial interest from the large retail groups has already been encouraging.

"Swisse's Hemp product rollout is a strategic move for the brand as we focus on offering innovative wellness solutions that respond to consumer shifts and growing demand," Swisse Managing Director Nick Mann commented.

"We are preparing our business for the legalisation of CBD in Australia, so we can take advantage of the market with product innovation in partnership with Bod," he added.

Swisse will undertake the sales and marketing campaigns, as well as in-store promotions.

To broaden its footprint and progress into the international market, Bod and Health and Happiness will continue working together to create new hemp-based products.

Bod's share price is up a steady 21.4 per cent and shares are trading for 17 cents each at 2:38 pm AEDT.


Subscribe


BDA by the numbers
More From The Market Herald
Allegra Orthopaedics (ASX:AMT) anticipates revenue increase for FY2020

" Allegra Orthopaedics (ASX:AMT) anticipates revenue increase for FY2020

Allegra Orthopaedics (AMT) is anticipating an increase in revenue for the 2020 financial year of 20 to 25 per cent compared to last year’s results.
Artemis raises $5.9M to clear all debt

" Creso Pharma (ASX:CPH) announces $2.1M share placement

Pharmaceutical cannabis company Creso Pharma (CPH) has tapped investors for $2.1 million through a share placement today.
Immutep (ASX:IMM) - CEO, Marc Voigt - The Market Herald

" Immutep (ASX:IMM) reports data from two separate cancer trials

Cancer treatment company Immutep (IMM) has released results from two separate anti-cancer trials using its leading drug, eftilagimod alpha.
Kazia Therapeutics (ASX:KZA) - CEO & Executive Director, Dr James Garner - The Market Herald

" Kazia Therapeutics (ASX:KZA) reports further positive data for paxalisib glioblastoma study

Kazia Therapeutics (KZA) is reporting further positive indications in its phase two study of novel drug paxalisib for glioblastoma.